Reference

1. The nomenclature of steroids. Recommendations 1989”. Eur. J. Biochem 1989;186(3):429–58. Doi:10.1111/j.1432-1033.1989.tb15228.x. PMID 2606099
2. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of Hospitalization for asthma. Jama. 1997 Mar 19;277(11):887-91
3. Barnes PJ, Pedersen S. Efficacy and safety of inhaled Corticosteroids in asthma. American Review of Respiratory Disease. 1993 Oct;148(4_pt_2):S1-26
4. B., Goodyear Smith F., Corticosteroid injections For painful shoulder: a meta-analysis. British Journal of General practice, 512 March 2005;55:224 -228.
5. Pikuleva IA. “Cytochrome P450s and cholesterol Homeostasis”. Pharmacol. Ther. 2006; 112(3): 761–73. Doi:10.1016/j.pharmthera.2006.05.014. PMID 16872679.
6. Hanukoglu I. “Steroidogenic enzymes: structure, Function, and role in regulation of steroid hormone Biosynthesis.”. J Steroid Biochem Mol Biol. Dec 1992; 43(8): 779-804. Doi:10.1016/0960-0760(92)90307-5.
7. Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic Agnes EC, Karen EC.
8. Asthma. N Engl J Med 2014; 371: 1189–1197 PJ. Glucocorticosteroids. Handb Exp Pharmacol 2017; 237: 93–115.
9. Ramsahai JM, Wark PA. Appropriate use of oral Corticosteroids for severe asthma. Medical Journal of Australia. 2018 Jul;209(S2):S18-21
10. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and Treatment of severe asthma. Eur Respir J 2014; 43:343–373.
11. Kauppi P, Peura S, Salimäki J, et al. Reduced severity And improved control of self-reported asthma in Finland during 2001–2010. Asia Pac Allergy 2015; 5: 32–39
12. Von Bülow A, Kriegbaum M, Backer V, et al. The Prevalence of severe asthma and low asthma control Among Danish adults. J Allergy Clin Immunol Pract 2014; 2: 759–767.
13. Ora J, Calzetta L, Matera MG, Cazzola M, Rogliani P. Advances with glucocorticoids in the treatment of Asthma: state of the art. Expert Opinion on Pharmacotherapy. 2020 Dec 11;21(18):2305-16.
14. Chhem RK, Kaplan PA, Dussault RG. Ultrasonography of musculoskeletal system. Radiol Clin North Am. 1994;32(2):275–893.
15. Iagnocco A, Meenagh G, Riente L, Filippucci E, et al. Ultrasound Imaging for the rheumatologist XXIX. Sonographic assessment Of the knee in patients with osteoarthritis. Clin Exp Rheumatol. 2010;28(5):643–6
16. Mundell L, Lindemann R, Douglas J. Monitoring long-termoral Corticosteroids. BMJ Open Quality. 2017;6:1–9.
17. Rhen T, Cidlowski J. Anti-infammatory action of glucocorticoids New mechanisms for old drugs. N Engl J Med. 2005;353:1711–23.
18. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in infammation and immunity. J Steroid Biochem Mol Biol. 2010;120:69–75.
19. Aljebab F, Choonara I, Conroy S. Systematic review of the toxicity of short-course oral corticosteroids in children. Arch Dis Child. 2016;10(4):365–70.
20. Fardet L, Kassar A, Cabane J, et al. Corticosteroid-induced adverse events in adults: frequency, screening andPrevention. Drug Saf 2007; 30: 861–881
21. World Health                     Organization (WHO).           Asthma           Fact           Sheet                       N°307. www.who.int/mediacentre/factsheets/fs307/en
22. Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilicAsthma. N Engl J Med 2014; 371: 1189–1197
23. Nair P, Wenzel S, Rabe KF, et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl JMed 2017; 376: 2448–245
24. Sadowska AM, Klebe B, Germonpré P, De Backer WA. Glucocorticoids as antioxidants in treatment of asthma and COPD. New application for an old medication? Steroids. 2007;72(1):1– 6. https://doi.org/10.1016/j.steroids.2006.10.007.
25. Agnes EC, Karen EC. The anti-infammatory and immunosuppressive efects of Glucocorticoids, recent developments and Mechanistic insights. Mol Cell Endocrinol. 2009;335:2–3